Mirtazapine is an antidepressant introduced by Organon International in 1996 used for the treatment of mild to severe depression. Although Mirtazapine has a tetracyclic chemical structure it is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA). Mirtazapine may be used in preference to an SSRI due to the fact that it causes fewer sexual dsyfunction problems. Due to its unique pharmacologic profile, mirtazapine is virtually devoid of anticholinergic, adrenolytic, and serotonin-related side effects.
Interestingly, its side effect profile can be used for benefit in certain clinical situations. The drowsiness, increased appetite, and weight gain it causes are useful in patients with depressive disorders with prominent sleep and appetite disturbances. In addition, it is quite useful in inpatient situations in which patients suffer from nausea since it also antagonizes the 5-HT3 receptor, the target of the popular anti-emetic ondansetron (Zofran®).
The usual starting dose for mirtazapine is 15 mg once daily, usually at bedtime (Due to the sedative nature and disturbed visual perception). Doses may be increased every 1-2 weeks up to a maximum dose of 45 mg daily. It may be taken with or without food. Dissolving tablets can even be taken without water.
Due to the sedative effects of Mirtazapine, alcohol should not be taken. Excessive sedation may result when it is used with other sedating drugs, such as benzodiazepines. Mirtazapine should not be used within 14 days of the use of a monoamine oxidase inhibitor because of the possibility that a hypertensive emergency will be triggered.
This article is licensed under the GNU Free Documentation License.
It uses material from the
"Mirtazapine".
Home Page • arts • business • computers • games • health • hospitals • home • kids & teens • news • physicians • recreation• reference • regional • science • shopping • society • sports • world